SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
14-Jun-24 6:00 PM View: | Aerovate Therapeutics, Inc. (AVTE) | 14-Jun-24 | Option Exercise | 15,000 | $2.14 | $32,100.00 | 299% 5.02K to 20.02K | |
14-Jun-24 6:00 PM View: | Aerovate Therapeutics, Inc. (AVTE) | 14-Jun-24 | Planned Option Sale | 15,000 | $25.03 | $375,450.00 | (75%) 20.02K to 5.02K | |
12-Apr-24 6:00 PM View: | Aerovate Therapeutics, Inc. (AVTE) | 10-Apr-24 | Option Exercise | 7,500 | $2.14 | $16,050.00 | 383% 1.96K to 9.46K | |
12-Apr-24 6:00 PM View: | Aerovate Therapeutics, Inc. (AVTE) | 10-Apr-24 | Planned Option Sale | 7,500 | $26.85 | $201,392.00 | (79%) 9.46K to 1.96K | |
03-Apr-24 6:00 PM View: | Aerovate Therapeutics, Inc. (AVTE) | 01-Apr-24 | Option Exercise | 12,495 | $2.14 | $26,739.30 | 638% 1.96K to 14.46K | |
03-Apr-24 6:00 PM View: | Aerovate Therapeutics, Inc. (AVTE) | 01-Apr-24 | Planned Option Sale | 12,495 | $31.23 | $390,208.00 | (86%) 14.46K to 1.96K | |
14-Mar-24 6:00 PM View: | Aerovate Therapeutics, Inc. (AVTE) | 13-Mar-24 | Option Exercise | 2,016 | $2.14 | $4,314.24 | 103% 1.96K to 3.98K | |
14-Mar-24 6:00 PM View: | Aerovate Therapeutics, Inc. (AVTE) | 13-Mar-24 | Planned Option Sale | 2,016 | $25.02 | $50,445.00 | (51%) 3.98K to 1.96K | |
14-Mar-24 6:00 PM View: | Aerovate Therapeutics, Inc. (AVTE) | 12-Mar-24 | Option Exercise | 2,051 | $2.14 | $4,389.14 | 105% 1.96K to 4.01K | |
14-Mar-24 6:00 PM View: | Aerovate Therapeutics, Inc. (AVTE) | 12-Mar-24 | Planned Option Sale | 2,051 | $25.05 | $51,369.60 | (51%) 4.01K to 1.96K | |
11-Mar-24 6:00 PM View: | Aerovate Therapeutics, Inc. (AVTE) | 11-Mar-24 | Option Exercise | 3,433 | $2.14 | $7,346.62 | 175% 1.96K to 5.39K | |
11-Mar-24 6:00 PM View: | Aerovate Therapeutics, Inc. (AVTE) | 11-Mar-24 | Planned Option Sale | 3,433 | $25.25 | $86,667.40 | (64%) 5.39K to 1.96K | |
11-Mar-24 6:00 PM View: | Aerovate Therapeutics, Inc. (AVTE) | 08-Mar-24 | Option Exercise | 114 | $2.14 | $243.96 | 6% 1.96K to 2.07K | |
11-Mar-24 6:00 PM View: | Aerovate Therapeutics, Inc. (AVTE) | 08-Mar-24 | Planned Option Sale | 114 | $25.00 | $2,850.00 | (5%) 2.07K to 1.96K | |
11-Mar-24 6:00 PM View: | Aerovate Therapeutics, Inc. (AVTE) | 07-Mar-24 | Option Exercise | 22,386 | $2.14 | $47,906.00 | 1142% 1.96K to 24.35K | |
11-Mar-24 6:00 PM View: | Aerovate Therapeutics, Inc. (AVTE) | 07-Mar-24 | Planned Option Sale | 22,386 | $25.00 | $559,688.00 | (92%) 24.35K to 1.96K | |
13-Dec-22 6:00 PM View: | Aerovate Therapeutics, Inc. (AVTE) | 12-Dec-22 | Option Exercise | 10,000 | $2.14 | $21,400.00 | 510% 1.96K to 11.96K | |
13-Dec-22 6:00 PM View: | Aerovate Therapeutics, Inc. (AVTE) | 12-Dec-22 | Planned Option Sale | 10,000 | $30.04 | $300,428.00 | (84%) 11.96K to 1.96K | |
13-Dec-22 6:00 PM View: | Aerovate Therapeutics, Inc. (AVTE) | 09-Dec-22 | Option Exercise | 3,969 | $2.14 | $8,493.66 | 203% 1.96K to 5.93K | |
13-Dec-22 6:00 PM View: | Aerovate Therapeutics, Inc. (AVTE) | 09-Dec-22 | Planned Option Sale | 3,969 | $24.38 | $96,765.30 | (67%) 5.93K to 1.96K | |
09-Dec-22 6:00 PM View: | Aerovate Therapeutics, Inc. (AVTE) | 08-Dec-22 | Option Exercise | 12,011 | $2.14 | $25,703.50 | 613% 1.96K to 13.97K | |
09-Dec-22 6:00 PM View: | Aerovate Therapeutics, Inc. (AVTE) | 08-Dec-22 | Planned Option Sale | 12,011 | $23.87 | $286,700.00 | (86%) 13.97K to 1.96K | |
09-Dec-22 6:00 PM View: | Aerovate Therapeutics, Inc. (AVTE) | 07-Dec-22 | Option Exercise | 11,637 | $2.14 | $24,903.20 | 594% 1.96K to 13.6K | |
09-Dec-22 6:00 PM View: | Aerovate Therapeutics, Inc. (AVTE) | 07-Dec-22 | Planned Option Sale | 11,637 | $19.77 | $230,083.00 | (86%) 13.6K to 1.96K | |
02-Dec-22 7:00 PM View: | Aerovate Therapeutics, Inc. (AVTE) | 30-Nov-22 | Option Exercise | 85 | $2.14 | $181.90 | 4% 1.96K to 2.04K | |
02-Dec-22 7:00 PM View: | Aerovate Therapeutics, Inc. (AVTE) | 30-Nov-22 | Planned Option Sale | 85 | $19.06 | $1,620.13 | (4%) 2.04K to 1.96K | |
28-Nov-22 5:00 PM View: | Aerovate Therapeutics, Inc. (AVTE) | 23-Nov-22 | Option Exercise | 1,261 | $2.14 | $2,698.54 | 64% 1.96K to 3.22K | |
28-Nov-22 5:00 PM View: | Aerovate Therapeutics, Inc. (AVTE) | 23-Nov-22 | Planned Option Sale | 1,261 | $19.07 | $24,048.30 | (39%) 3.22K to 1.96K | |
22-Nov-22 8:00 PM View: | Aerovate Therapeutics, Inc. (AVTE) | 22-Nov-22 | Option Exercise | 174 | $2.14 | $372.36 | 9% 1.96K to 2.13K | |
22-Nov-22 8:00 PM View: | Aerovate Therapeutics, Inc. (AVTE) | 22-Nov-22 | Planned Option Sale | 174 | $19.01 | $3,308.11 | (8%) 2.13K to 1.96K | |
22-Nov-22 8:00 PM View: | Aerovate Therapeutics, Inc. (AVTE) | 21-Nov-22 | Option Exercise | 2 | $2.14 | $4.28 | < 1% 1.96K to 1.96K | |
22-Nov-22 8:00 PM View: | Aerovate Therapeutics, Inc. (AVTE) | 21-Nov-22 | Planned Option Sale | 2 | $19.00 | $38.00 | (< 1%) 1.96K to 1.96K | |
22-Nov-22 8:00 PM View: | Aerovate Therapeutics, Inc. (AVTE) | 18-Nov-22 | Option Exercise | 861 | $2.14 | $1,842.54 | 44% 1.96K to 2.82K | |
22-Nov-22 8:00 PM View: | Aerovate Therapeutics, Inc. (AVTE) | 18-Nov-22 | Planned Option Sale | 861 | $19.52 | $16,805.00 | (31%) 2.82K to 1.96K |